Literature DB >> 11231077

Developmentally regulated expression of Smad3, Smad4, Smad6, and Smad7 involved in TGF-beta signaling.

K Luukko1, A Ylikorkala, T P Mäkelä.   

Abstract

Transforming growth factor-beta (TGF-beta) signaling is mediated from serine/threonine kinase receptors to transcriptional responses via Smad proteins. Here comparison of mRNA expression of Smad3-7 in mouse embryos (E9-E15) revealed developmentally regulated distinct expression patterns for Smad3, 4, 6, and 7. Smad3 was prominently expressed in the differentiating (from E10) central nervous system, but also in developing bones, branchial arches and epithelium of various tissues. Smad4 mostly showed ubiquitous expression, but in E15 embryos, a pronounced signal appeared in epithelial crypts of the gut. Inhibitory Smad6 and Smad7 were coexpressed at high levels in developing cardiovascular system from the earliest stages studied. In contrast, Smad6 was selectively expressed at high levels, e.g. in intramembranous bone whereas Smad7 was prominent in seminiferous tubules of the testis, demonstrating distinct expression of these genes in non-cardiovascular tissues.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11231077     DOI: 10.1016/s0925-4773(00)00556-6

Source DB:  PubMed          Journal:  Mech Dev        ISSN: 0925-4773            Impact factor:   1.882


  16 in total

1.  Trigenic neural crest-restricted Smad7 over-expression results in congenital craniofacial and cardiovascular defects.

Authors:  Sunyong Tang; Paige Snider; Antony B Firulli; Simon J Conway
Journal:  Dev Biol       Date:  2010-05-08       Impact factor: 3.582

Review 2.  Transforming growth factor beta signaling in adult cardiovascular diseases and repair.

Authors:  Thomas Doetschman; Joey V Barnett; Raymond B Runyan; Todd D Camenisch; Ronald L Heimark; Henk L Granzier; Simon J Conway; Mohamad Azhar
Journal:  Cell Tissue Res       Date:  2011-09-28       Impact factor: 5.249

3.  Smad4 overexpression causes germ cell ablation and leydig cell hyperplasia in transgenic mice.

Authors:  Anita Narula; Signe Kilen; Eva Ma; Jessica Kroeger; Erwin Goldberg; Teresa K Woodruff
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

Review 4.  Smad4 transcriptional pathways and angiogenesis.

Authors:  Irmgard Schwarte-Waldhoff; Wolff Schmiegel
Journal:  Int J Gastrointest Cancer       Date:  2002

Review 5.  Inhibitory SMADs: potential regulators of ovarian function.

Authors:  Qinglei Li
Journal:  Biol Reprod       Date:  2014-12-30       Impact factor: 4.285

6.  A 4.3 kb Smad7 promoter is able to specify gene expression during mouse development.

Authors:  Xubao Liu; Qian Chen; Chenzhong Kuang; Meiyu Zhang; Yiwen Ruan; Zao C Xu; Zhenzhen Wang; Yan Chen
Journal:  Biochim Biophys Acta       Date:  2007-01-19

7.  Protocadherin-1 binds to SMAD3 and suppresses TGF-β1-induced gene transcription.

Authors:  Grissel Faura Tellez; Karl Vandepoele; Uilke Brouwer; Henk Koning; Robin M Elderman; Tillie-Louise Hackett; Brigitte W M Willemse; John Holloway; Frans Van Roy; Gerard H Koppelman; Martijn C Nawijn
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-07-24       Impact factor: 5.464

8.  Smad7 is required for the development and function of the heart.

Authors:  Qian Chen; Hanying Chen; Dawei Zheng; Chenzhong Kuang; Hong Fang; Bingyu Zou; Wuqiang Zhu; Guixue Bu; Ting Jin; Zhenzhen Wang; Xin Zhang; Ju Chen; Loren J Field; Michael Rubart; Weinian Shou; Yan Chen
Journal:  J Biol Chem       Date:  2008-10-24       Impact factor: 5.157

9.  Nodal/activin signaling promotes male germ cell fate and suppresses female programming in somatic cells.

Authors:  Quan Wu; Kohei Kanata; Rie Saba; Chu-Xia Deng; Hiroshi Hamada; Yumiko Saga
Journal:  Development       Date:  2012-12-05       Impact factor: 6.868

10.  Generation of Smad7(-Cre) recombinase mice: A useful tool for the study of epithelial-mesenchymal transformation within the embryonic heart.

Authors:  Paige Snider; Sunyong Tang; Goldie Lin; Jian Wang; Simon J Conway
Journal:  Genesis       Date:  2009-07       Impact factor: 2.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.